Publication | Closed Access

6-Bromoindirubin-3′-Oxime Suppresses LPS-Induced Inflammation via Inhibition of the TLR4/NF-κB and TLR4/MAPK Signaling Pathways

InflammationAnti-inflammatoryTlr4/mapk Signaling PathwaysMedicineImmunologyImmune RegulationInflammation BiologyChronic InflammationInnate ImmunityImmune FunctionPharmacologyInflammatory DiseaseCell SignalingOxidative Stress